TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Amylin Pharmaceuticals, Inc. Investor Investigation Over Possible Securities Laws Violations

  • If you are an investor in shares of Amylin Pharmaceuticals, Inc. (Public, NASDAQ:AMLN), and/or have any information relating to the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

After Amylin Pharmaceuticals lost more than 50% in stock value an investigation on behalf of investors in Amylin Pharmaceuticals (NASDAQ: AMLN) shares concerning potential violations of Federal Securities laws in connection with the New Drug Application for Amylins diabetes drug BYDUREON was announced. The investigation by a law firm on behalf of investors in AMLN shares concerns whe...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: